301 related articles for article (PubMed ID: 23408651)
1. Inhibition of Ca²⁺/calmodulin-dependent protein kinase kinase 2 stimulates osteoblast formation and inhibits osteoclast differentiation.
Cary RL; Waddell S; Racioppi L; Long F; Novack DV; Voor MJ; Sankar U
J Bone Miner Res; 2013 Jul; 28(7):1599-610. PubMed ID: 23408651
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of CaMKK2 reverses age-associated decline in bone mass.
Pritchard ZJ; Cary RL; Yang C; Novack DV; Voor MJ; Sankar U
Bone; 2015 Jun; 75():120-7. PubMed ID: 25724145
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of CaMKK2 Enhances Fracture Healing by Stimulating Indian Hedgehog Signaling and Accelerating Endochondral Ossification.
Williams JN; Kambrath AV; Patel RB; Kang KS; Mével E; Li Y; Cheng YH; Pucylowski AJ; Hassert MA; Voor MJ; Kacena MA; Thompson WR; Warden SJ; Burr DB; Allen MR; Robling AG; Sankar U
J Bone Miner Res; 2018 May; 33(5):930-944. PubMed ID: 29314250
[TBL] [Abstract][Full Text] [Related]
4. Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation.
Kim JY; Cheon YH; Kwak SC; Baek JM; Yoon KH; Lee MS; Oh J
J Bone Miner Res; 2014 Jul; 29(7):1541-53. PubMed ID: 25832436
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological inhibition of CaMKK2 with the selective antagonist STO-609 regresses NAFLD.
York B; Li F; Lin F; Marcelo KL; Mao J; Dean A; Gonzales N; Gooden D; Maity S; Coarfa C; Putluri N; Means AR
Sci Rep; 2017 Sep; 7(1):11793. PubMed ID: 28924233
[TBL] [Abstract][Full Text] [Related]
6. IGFBP-2 stimulates calcium/calmodulin-dependent protein kinase kinase 2 activation leading to AMP-activated protein kinase induction which is required for osteoblast differentiation.
Xi G; D'Costa S; Wai C; Xia SK; Cox ZC; Clemmons DR
J Cell Physiol; 2019 Dec; 234(12):23232-23242. PubMed ID: 31155724
[TBL] [Abstract][Full Text] [Related]
7. Dasatinib as a bone-modifying agent: anabolic and anti-resorptive effects.
Garcia-Gomez A; Ocio EM; Crusoe E; Santamaria C; Hernández-Campo P; Blanco JF; Sanchez-Guijo FM; Hernández-Iglesias T; Briñón JG; Fisac-Herrero RM; Lee FY; Pandiella A; San Miguel JF; Garayoa M
PLoS One; 2012; 7(4):e34914. PubMed ID: 22539950
[TBL] [Abstract][Full Text] [Related]
8. CaMKK2 is inactivated by cAMP-PKA signaling and 14-3-3 adaptor proteins.
Langendorf CG; O'Brien MT; Ngoei KRW; McAloon LM; Dhagat U; Hoque A; Ling NXY; Dite TA; Galic S; Loh K; Parker MW; Oakhill JS; Kemp BE; Scott JW
J Biol Chem; 2020 Nov; 295(48):16239-16250. PubMed ID: 32913128
[TBL] [Abstract][Full Text] [Related]
9. Osteocyte-Derived CaMKK2 Regulates Osteoclasts and Bone Mass in a Sex-Dependent Manner through Secreted Calpastatin.
Williams JN; Irwin M; Li Y; Kambrath AV; Mattingly BT; Patel S; Kittaka M; Collins RN; Clough NA; Doud EH; Mosley AL; Bellido T; Bruzzaniti A; Plotkin LI; Trinidad JC; Thompson WR; Bonewald LF; Sankar U
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902150
[TBL] [Abstract][Full Text] [Related]
10. Loss of phosphatidylinositol-4-phosphate 5-kinase type-1 gamma (Pip5k1c) in mesenchymal stem cells leads to osteopenia by impairing bone remodeling.
Yan Q; Gao H; Yao Q; Ling K; Xiao G
J Biol Chem; 2022 Mar; 298(3):101639. PubMed ID: 35090892
[TBL] [Abstract][Full Text] [Related]
11. Hymenialdisine: A Marine Natural Product That Acts on Both Osteoblasts and Osteoclasts and Prevents Estrogen-Dependent Bone Loss in Mice.
Wang Q; Chen D; Jin H; Ye Z; Wang C; Chen K; Kuek V; Xu K; Qiu H; Chen P; Song D; Zhao J; Liu Q; Davis RA; Song F; Xu J
J Bone Miner Res; 2020 Aug; 35(8):1582-1596. PubMed ID: 32286705
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of glycogen synthase kinase-3β is required for osteoclast differentiation.
Jang HD; Shin JH; Park DR; Hong JH; Yoon K; Ko R; Ko CY; Kim HS; Jeong D; Kim N; Lee SY
J Biol Chem; 2011 Nov; 286(45):39043-50. PubMed ID: 21949120
[TBL] [Abstract][Full Text] [Related]
13. Regulators of G protein signaling 12 promotes osteoclastogenesis in bone remodeling and pathological bone loss.
Yuan X; Cao J; Liu T; Li YP; Scannapieco F; He X; Oursler MJ; Zhang X; Vacher J; Li C; Olson D; Yang S
Cell Death Differ; 2015 Dec; 22(12):2046-57. PubMed ID: 25909889
[TBL] [Abstract][Full Text] [Related]
14. Using the fluorescent properties of STO-609 as a tool to assist structure-function analyses of recombinant CaMKK2.
Gerner L; Munack S; Temmerman K; Lawrence-Dörner AM; Besir H; Wilmanns M; Jensen JK; Thiede B; Mills IG; Morth JP
Biochem Biophys Res Commun; 2016 Jul; 476(2):102-7. PubMed ID: 27178209
[TBL] [Abstract][Full Text] [Related]
15. Calcium/calmodulin-dependent kinase kinase 2 regulates hematopoietic stem and progenitor cell regeneration.
Racioppi L; Lento W; Huang W; Arvai S; Doan PL; Harris JR; Marcon F; Nakaya HI; Liu Y; Chao N
Cell Death Dis; 2017 Oct; 8(10):e3076. PubMed ID: 28981105
[TBL] [Abstract][Full Text] [Related]
16. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
17. Bone Morphogenetic Protein-2 (BMP-2) Activates NFATc1 Transcription Factor via an Autoregulatory Loop Involving Smad/Akt/Ca2+ Signaling.
Mandal CC; Das F; Ganapathy S; Harris SE; Choudhury GG; Ghosh-Choudhury N
J Biol Chem; 2016 Jan; 291(3):1148-61. PubMed ID: 26472929
[TBL] [Abstract][Full Text] [Related]
18. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice.
Cheon YH; Kim JY; Baek JM; Ahn SJ; Jun HY; Erkhembaatar M; Kim MS; Lee MS; Oh J
J Bone Miner Res; 2016 Feb; 31(2):403-15. PubMed ID: 26255791
[TBL] [Abstract][Full Text] [Related]
19. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
Kupisiewicz K
Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
[TBL] [Abstract][Full Text] [Related]
20. Hyperactivation of MEK/ERK pathway by Ca
Najar MA; Aravind A; Dagamajalu S; Sidransky D; Ashktorab H; Smoot DT; Gowda H; Prasad TSK; Modi PK; Chatterjee A
Mol Carcinog; 2021 Nov; 60(11):769-783. PubMed ID: 34437731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
